Nordic MuBio

COMBI IC Reagent: IgG Negative Control (FITC) and IgG Negative Control (PE)

Product Code:
 
GIC-201
Product Group:
 
Isotype Controls
Supplier:
 
Nordic MuBio
Antibody Isotype:
 
IgG1
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
VI-AP and VI-AP
Regulatory Status:
 
RUO
Target Species:
 
Mouse
Application:
 
Flow Cytometry
Storage:
 
Nordic-MUbio monoclonal antibody reagents contain optimal concentrations of affinity-purified antibody. For stability reasons this monoclonal antibody solution contains sodium azide. These reagents should be stored at 2-8°C (DO NOT FREEZE!) and protec
 

No additional charges, what you see is what you pay! *

CodeSizePrice
GIC-2011 ml£227.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Netherlands.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Applications Description:
Permeabilization and Staining Procedure
- In combination with our Permeabilization Kit FIX&PERM? (Cat. No. GAS-002) intracellular isotype controls can be easily stained in cell suspensions.
- For each sample to be analyzed add 50 ?l of whole blood, bone marrow or mononuclear cell suspension in a 5ml tube
- Add 100 ?l of Reagent A (Fixation Medium, stored and used at room temperature)
- Incubate for 15 minutes at room temperature
- Add 5 ml phosphate buffered saline and centrifuge cells for 5 minutes at 300 g
- Remove supernatant and add to cell pellet 100 ?l Reagent B (Permeabilization Medium) and 20 ?l of COMBI-IC Negative Control antibody conjugate.
- Vortex at low speed for 1-2 seconds
- Incubate for 15 minutes at room temperature
- Wash cells with phosphate buffered saline as described above
- Remove supernatant and resuspend cells in sheath fluid for immediate analysis or resuspend cells in 0.5 ml 1.0 % formaldehyde and store them at 2-8°C in the dark. Analyze
fixed cells within 24 hours.
Background:
This ready to use Negative Control reagent contains a combination of fluorescein and phycoerythrin conjugated mouse immunoglobulin molecules of IgG1 isotype, which have been selected on the basis of their binding characteristics: no specific binding to human intracellular or cell surface antigens, same low range of nonspecific binding to human leukocytes as other COMBI-IC-Reagents. Like all other COMBI-IC-reagents, this reagent should be used in combination with our FIX&PERM? Cell Permeabilization Kit (Cat.No. GAS-002)

These isotype control IgG1 are suitable as negative controls to be used in combination with COMBI-IC reagents for the:

- Enumeration of Myeloid Cells
- Analysis of Myeloid Differentiation Stage
- Enumeration of B-cells and Precursors
- Enumeration of T-cells and Precursors
- Analysis of Leukemia Cells
- Analysis of Immunodeficiency States

Results must be put within the context of other diagnostic tests as well as the clinical history of the patient by a certified professional before final interpretation.
Caution:
For professional users only.
This reagent contains sodium azide. To avoid the development
of hazardous conditions, reagents containing azide should be
diluted in running water prior to be discarded. Similar to the work
with other biological products, proper handling procedures are
recommended.
Formulation:
PBS pH 7.2, 1% BSA, 0.05% NaN3
Label:
FITC|PE
Product:
1ml of FITC- and PE-conjugated VI-AP in PBS pH 7.2, 1% BSA, and 0.05% NaN3, approximately 50 tests.
Product Form:
FITC and PE
Specificity:
VI-AP reacts with calf intestine alkaline phosphatase and does not show cross-reactivity with human proteins.

References

1. J. L. Clarke, W. Watkins, J Biol Chem 271, 10317 (1996).
2.
R. N. Knibbs et al., J Cell Biol 133, 911 (1996).

3. B. Kniep et al., J Biochem (Tokyo) 119, 456 (1996).
4.
A. J. Wagers, L. M. Stoolman, R. Kannagi, R. Craig, G. S. Kansas, J Immunol 159, 1917 (1997).
5.
M. Noguchi, N. Sato, H. Sugimori, K. Mori, K. Oshimi, Leuk Res 25, 847 (2001).
6.
W. M. Watkins, J. L. Clarke, Adv Exp Med Biol 491, 231 (2001).